DE60118914T2 - Pharmazeutische zusammensetzungen die acryloyl-substituierte distamycin-derivate und topoisomerase i und ii inhibitoren enthalten - Google Patents

Pharmazeutische zusammensetzungen die acryloyl-substituierte distamycin-derivate und topoisomerase i und ii inhibitoren enthalten Download PDF

Info

Publication number
DE60118914T2
DE60118914T2 DE60118914T DE60118914T DE60118914T2 DE 60118914 T2 DE60118914 T2 DE 60118914T2 DE 60118914 T DE60118914 T DE 60118914T DE 60118914 T DE60118914 T DE 60118914T DE 60118914 T2 DE60118914 T2 DE 60118914T2
Authority
DE
Germany
Prior art keywords
amino
topoisomerase
methyl
inhibitor
pyrrol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60118914T
Other languages
German (de)
English (en)
Other versions
DE60118914D1 (de
Inventor
Cristina Maria GERONI
Paolo Cozzi
Italo Beria
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nerviano Medical Sciences SRL
Original Assignee
Nerviano Medical Sciences SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nerviano Medical Sciences SRL filed Critical Nerviano Medical Sciences SRL
Application granted granted Critical
Publication of DE60118914D1 publication Critical patent/DE60118914D1/de
Publication of DE60118914T2 publication Critical patent/DE60118914T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE60118914T 2000-06-23 2001-06-20 Pharmazeutische zusammensetzungen die acryloyl-substituierte distamycin-derivate und topoisomerase i und ii inhibitoren enthalten Expired - Lifetime DE60118914T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0015444.3A GB0015444D0 (en) 2000-06-23 2000-06-23 Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and topoisomerase I and II inhibitors
GB0015444 2000-06-23
PCT/EP2001/007059 WO2001097789A2 (en) 2000-06-23 2001-06-20 Pharmaceutical compositions comprising acryloyl distamycin derivatives and topoisomerase i and ii inhibitors

Publications (2)

Publication Number Publication Date
DE60118914D1 DE60118914D1 (de) 2006-05-24
DE60118914T2 true DE60118914T2 (de) 2006-12-21

Family

ID=9894285

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60118914T Expired - Lifetime DE60118914T2 (de) 2000-06-23 2001-06-20 Pharmazeutische zusammensetzungen die acryloyl-substituierte distamycin-derivate und topoisomerase i und ii inhibitoren enthalten

Country Status (27)

Country Link
US (1) US20030162722A1 (xx)
EP (1) EP1292290B1 (xx)
JP (1) JP2003535890A (xx)
KR (1) KR100853955B1 (xx)
CN (1) CN1241573C (xx)
AT (1) ATE323483T1 (xx)
AU (2) AU2001278463B2 (xx)
BR (1) BR0111813A (xx)
CA (1) CA2411172C (xx)
CZ (1) CZ20024155A3 (xx)
DE (1) DE60118914T2 (xx)
DK (1) DK1292290T3 (xx)
EA (1) EA006684B1 (xx)
EE (1) EE05319B1 (xx)
ES (1) ES2261448T3 (xx)
GB (1) GB0015444D0 (xx)
HK (1) HK1054334B (xx)
HU (1) HUP0301257A2 (xx)
IL (1) IL153177A0 (xx)
MX (1) MXPA02012163A (xx)
NO (1) NO329783B1 (xx)
NZ (1) NZ523000A (xx)
PL (1) PL200503B1 (xx)
PT (1) PT1292290E (xx)
SK (1) SK287549B6 (xx)
WO (1) WO2001097789A2 (xx)
ZA (1) ZA200209834B (xx)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0015447D0 (en) * 2000-06-23 2000-08-16 Pharmacia & Upjohn Spa Combined therapy against tumors comprising substituted acryloyl derivates and alkylating agents
GB0015444D0 (en) * 2000-06-23 2000-08-16 Pharmacia & Upjohn Spa Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and topoisomerase I and II inhibitors
AU2002352090B8 (en) * 2002-01-02 2008-06-19 Nerviano Medical Sciences S.R.L. Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and protein kinase (serine/threonine kinase) inhibitors
CN100438913C (zh) * 2004-11-22 2008-12-03 山东蓝金生物工程有限公司 一种抗癌药物组合物
MD23Z (ro) * 2008-12-02 2010-01-31 Василе ЖОВМИР Metodă de tratament diferenţiat al carcinomului lobular in situ neinvaziv al glandei mamare
MD36Z (ro) * 2008-12-02 2010-01-31 Василе ЖОВМИР Metodă de tratament diferenţiat al carcinomului ductal in situ neinvaziv al glandei mamare
MD35Z (ro) * 2008-12-02 2010-01-31 Василе ЖОВМИР Metodă de apreciere a riscului dezvoltării carcinomului neinvaziv in situ al glandei mamare
MD24Z (ro) * 2008-12-02 2010-01-31 Василе ЖОВМИР Metodă de tratament diferenţiat al carcinomului neinvaziv al glandei mamare
CA2803646A1 (en) 2010-07-02 2012-01-05 Angiochem Inc. Short and d-amino acid-containing polypeptides for therapeutic conjugates and uses thereof
CN109718228A (zh) * 2017-10-30 2019-05-07 沈阳药科大学 米托蒽醌的抗肿瘤淋巴转移作用及其药物制剂

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9615692D0 (en) * 1996-07-25 1996-09-04 Pharmacia Spa Acryloyl substituted distamycin derivatives, process for preparing them, and their use as antitumor and antiviral agents
GB9623522D0 (en) 1996-11-11 1997-01-08 Pharmacia & Upjohn Spa Benzoheterocycle distamycin derivatives process for preparing them and their use as antitumour and antiviral agents
GB9727524D0 (en) * 1997-12-31 1998-02-25 Pharmacia & Upjohn Spa Synergistic antitumor composition containing a biologically active ureido compound
GB9806692D0 (en) * 1998-03-27 1998-05-27 Pharmacia & Upjohn Spa Benzoheterocyclic distamycin derivatives, process for preparing them and their use as antitumour agents
GB0015444D0 (en) * 2000-06-23 2000-08-16 Pharmacia & Upjohn Spa Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and topoisomerase I and II inhibitors

Also Published As

Publication number Publication date
PT1292290E (pt) 2006-08-31
EA006684B1 (ru) 2006-02-24
PL200503B1 (pl) 2009-01-30
EP1292290B1 (en) 2006-04-19
CA2411172A1 (en) 2001-12-27
IL153177A0 (en) 2003-06-24
ATE323483T1 (de) 2006-05-15
HUP0301257A2 (hu) 2003-08-28
NZ523000A (en) 2005-12-23
WO2001097789A3 (en) 2002-05-16
SK287549B6 (sk) 2011-01-04
MXPA02012163A (es) 2003-04-25
AU7846301A (en) 2002-01-02
DK1292290T3 (da) 2006-07-10
HK1054334B (zh) 2006-09-22
ZA200209834B (en) 2003-12-04
KR20030019448A (ko) 2003-03-06
WO2001097789A2 (en) 2001-12-27
ES2261448T3 (es) 2006-11-16
GB0015444D0 (en) 2000-08-16
HK1054334A1 (en) 2003-11-28
DE60118914D1 (de) 2006-05-24
CA2411172C (en) 2009-11-17
NO329783B1 (no) 2010-12-13
PL360297A1 (en) 2004-09-06
EA200300060A1 (ru) 2003-04-24
CN1241573C (zh) 2006-02-15
SK18332002A3 (sk) 2003-07-01
NO20026078L (no) 2002-12-18
BR0111813A (pt) 2003-05-20
CN1437474A (zh) 2003-08-20
EE200200681A (et) 2004-06-15
NO20026078D0 (no) 2002-12-18
CZ20024155A3 (cs) 2003-04-16
AU2001278463B2 (en) 2006-02-23
EE05319B1 (et) 2010-08-16
JP2003535890A (ja) 2003-12-02
KR100853955B1 (ko) 2008-08-25
US20030162722A1 (en) 2003-08-28
EP1292290A2 (en) 2003-03-19

Similar Documents

Publication Publication Date Title
DE60014873T2 (de) Synergistische zusammensetzungen zur krebsbehandlung
DE69918819T2 (de) Antikrebs-zusammensetzung enthaltend eine synergistische kombination bestehend aus einem anthracyclin-derivat mit einen camptothecin-derivat
DE60118914T2 (de) Pharmazeutische zusammensetzungen die acryloyl-substituierte distamycin-derivate und topoisomerase i und ii inhibitoren enthalten
DE3319347A1 (de) Arzneimittel zur verstaerkung der therapeutischen wirkung von antitumormitteln und deren verwendung
US6576612B1 (en) Antitumor therapy comprising distamycin derivatives
AU2002221622A1 (en) Antitumor therapy comprising distamycin derivatives
AU2001278463A1 (en) Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and topoisomerase i and ii inhibitors
DE60128472T2 (de) Kombinierte tumortherapie auf der basis von distamycin-acryloylderivaten und alkylierungsmitteln
DE60021075T2 (de) Verwendung von 1,4-benzothiazepinderivaten als arzneimittel zur überwindung einer resistenz gegenüber einem arzneimittel gegen krebs
DE69814089T2 (de) Verwendung von einem draflazin analog zur schmerzbehandlung
DE60210329T2 (de) Kombinierte tumortherapie auf der basis von substituierten acryloyl-distamycin-derivaten und protein-kinase (serin/threonin-kinase) inhibitoren
KR100861668B1 (ko) 치환된 아크릴로일 디스타마이신 유도체, 탁산 및/또는 항대사물질을 포함하는, 항종양 배합 치료제
DE69735383T2 (de) Methode zur Inhibierung von HEREGULIN und seines Rezeptors sowie Verwendung zur Inhibierung von Krebszellen
DE69534535T2 (de) Verfahren und mittel zur verminderung der tumorentwicklung mittels einer kombination aus einer taxanverbindung und einer tellur und/oder selenverbindung
DE2314387C3 (de) Arzneimittel zur Behandlung bösartiger Neubildungen
US20070249651A1 (en) Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and topoisomerase I and II inhibitors

Legal Events

Date Code Title Description
8364 No opposition during term of opposition